MORRISVILLE - The life science commercialization company TrialCard has a new chief executive.
Scott Dulitz has earned a promotion to the role of CEO, and was appointed to the role by the company’s board of directors, according to a statement from the company.
Dulitz has been employed at the Morrisville-based firm since 2015 and most recently was its president and chief strategy officer.
“I am honored to become CEO of TrialCard,” said Dulitz in the company’s statement.
In October 2021, the company’s CEO, Mark Bouck resigned. Dulitz was promoted at the time to the role of president and chief strategy officer, according to báo cáo trước từ WRAL TechWire.
Odyssey Investment Partners is the majority shareholder in the company, according to a tuyên bố trước from the firm about the leadership change.
“Building on our recent success, we will remain focused on advancing our business through strategic technology investments, pursuing opportunities to connect our capabilities across strategic consulting and payer intelligence, and identifying new avenues for growth that address macro industry trends to diversify our platform,” said Dulitz in the statement.
Dulitz previously served as the head of corporate development and a senior vice president, enterprise strategy, according to the company.
